FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction

FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction

The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with pain reduction in patients 18 years of age and older with diagnosed chronic lower back pain.

Source: FDA

Read more

  • American Academy of Orthopaedic Surgeons
  • North American Spine Society
  • Fairview
  • Minnesota Valley Surgery Center
  • Eagan Orthopedic Surgery Center
  • Haemochromatosis Australia - Inherited iron overload disorder